Ajooni Biotech Limited
Ajooni Biotech Limited manufactures and sells cattle feed in India. Its portfolio includes cattle feed chips, camel and pig feed, cotton oil cakes, mustard oil cakes, and feed supplements. The company was incorporated in 2010 and is based in Mohali, India.
Ajooni Biotech Limited (AJOONI) - Total Assets
Latest total assets as of December 2025: ₹1.14 Billion INR
Based on the latest financial reports, Ajooni Biotech Limited (AJOONI) holds total assets worth ₹1.14 Billion INR as of December 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Ajooni Biotech Limited - Total Assets Trend (2013–2025)
This chart illustrates how Ajooni Biotech Limited’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Ajooni Biotech Limited - Asset Composition Analysis
Current Asset Composition (March 2025)
Ajooni Biotech Limited's total assets of ₹1.14 Billion consist of 65.2% current assets and 34.8% non-current assets.
| Asset Category | Amount (INR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₹0.00 | 7.2% |
| Accounts Receivable | ₹295.23 Million | 31.1% |
| Inventory | ₹239.87 Million | 25.2% |
| Property, Plant & Equipment | ₹112.26 Million | 11.8% |
| Intangible Assets | ₹4.79 Million | 0.5% |
| Goodwill | ₹0.00 | 0.0% |
Asset Composition Trend (2013–2025)
This chart illustrates how Ajooni Biotech Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Ajooni Biotech Limited's current assets represent 65.2% of total assets in 2025, a decrease from 100.0% in 2013.
- Cash Position: Cash and equivalents constituted 7.2% of total assets in 2025, down from 100.0% in 2013.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2013.
- Asset Diversification: The largest asset category is accounts receivable at 31.1% of total assets.
Ajooni Biotech Limited Competitors by Total Assets
Key competitors of Ajooni Biotech Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
General Mills Inc
NYSE:GIS
|
USA | $32.55 Billion |
|
Maniker F & G Co. Ltd
KQ:195500
|
Korea | ₩123.42 Billion |
|
Xiwang Foodstuffs Co Ltd
SHE:000639
|
China | CN¥6.08 Billion |
|
Nanfang Black Sesame Group Co Ltd
SHE:000716
|
China | CN¥4.57 Billion |
|
CNFC Overseas Fishery Co Ltd
SHE:000798
|
China | CN¥5.88 Billion |
|
Henan Shuanghui Investment & Development Co Ltd
SHE:000895
|
China | CN¥40.64 Billion |
|
Xinjiang Chalkis Co Ltd
SHE:000972
|
China | CN¥1.25 Billion |
|
Daehan Flour Mills Co Ltd
KO:001130
|
Korea | ₩1.61 Trillion |
Ajooni Biotech Limited - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Ajooni Biotech Limited generates 1.21x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Ajooni Biotech Limited generates $ 3.41 in net profit.
Ajooni Biotech Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.20 | 18.13 | 2.05 |
| Quick Ratio | 2.00 | 13.08 | 1.53 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | ₹458.52 Million | ₹ 709.16 Million | ₹ 109.51 Million |
Ajooni Biotech Limited - Advanced Valuation Insights
This section examines the relationship between Ajooni Biotech Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.99 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | 100.0% |
| Total Assets | ₹950.51 Million |
| Market Capitalization | $5.94 Million USD |
Valuation Analysis
Below Book Valuation: The market values Ajooni Biotech Limited's assets below their book value (0.01 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Ajooni Biotech Limited's assets grew by 100.0% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Ajooni Biotech Limited (2013–2025)
The table below shows the annual total assets of Ajooni Biotech Limited from 2013 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-03-31 | ₹950.51 Million | +100.02% |
| 2024-03-31 | ₹475.20 Million | -19.09% |
| 2023-03-31 | ₹587.31 Million | +102.40% |
| 2022-03-31 | ₹290.18 Million | +3.54% |
| 2021-03-31 | ₹280.26 Million | +21.50% |
| 2020-03-31 | ₹230.67 Million | +26.40% |
| 2019-03-31 | ₹182.50 Million | -5.51% |
| 2018-03-31 | ₹193.14 Million | +50.23% |
| 2017-03-31 | ₹128.56 Million | +429.44% |
| 2016-03-31 | ₹24.28 Million | +50.51% |
| 2015-03-31 | ₹16.13 Million | +223.57% |
| 2014-03-31 | ₹4.99 Million | +6637.84% |
| 2013-03-31 | ₹74.00K | -- |